{"ticker": {"uuid": "cdd69a93-4466-4dd1-84c5-99c098804d49", "symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-says-study-shows-115035587.html", "source_name": "MT Newswires", "published_at": "2026-07-15T11:50:35+00:00", "published_display": "15 Jul 2026 11:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio\u2019s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-xpro1595-prevents-brain-110000293.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T11:00:00+00:00", "published_display": "15 Jul 2026 11:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio And 2 Other Promising Penny Stocks To Consider", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T17:11:43+00:00", "published_display": "13 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "INmune Bio Inc (INMB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5UcElqMTJFWTktaW5zQzk4RkVjNldCS3ZQbzVsZlBfNTlJdlI1anItZnlfOG04RjNRV2N3dXBwNmVtd2s0LVJZa0NfTVFnbnVldjlsVzBDU1ppQzVDd0dQOWpZZmtPMTJUZXZ2UkFxaw?oc=5", "source_name": "TradingKey", "published_at": "2026-07-12T07:00:00+00:00", "published_display": "12 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer\u2019s Disease at AAIC", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-present-positive-phase-110000414.html", "source_name": "GlobeNewswire", "published_at": "2026-07-09T11:00:00+00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio says XPro imaging data at AAIC show early Alzheimer\u2019s brain changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQeE9ET2RKbUdaZFZSQkxsOWNOR3RDVUFzX1M4eDVzQ3JObUE5dFh1YzdKNmF0QWxvLXotN2RQa1JtLXhSTUlleVFDNF9uUWxZZVJTV3htNWtiNVJmY0NIQnMyY19hVGJDRnl1VVV6VGUxNi1uVmtfOXNETDlFa1lZZ1ZZY2JFR1JGQW9sZHY2ZnpOSlVPWkRVLUVhNHZKUzNLcXJnWEdjcks1YzViRERndFpwTklMdEswa0ZzRw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T11:00:00+00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 INmune Bio Inc For: 7 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNTE02MDJlazkzVUNFLUpiMFR3N3BsWHFFZzBCdW9XcHRWQm40TG9XbWtaaVpPMDZiazFjVEdvZFRxSGFzQkxwNWxsbkFZLXYwWnZRY21DZmZQT0NQd3hOMmRKZjlfckhDZHNJMlloS0tIWmFvVXh2d2xMS18yOVJyc3ExSTNVMFZaRWhMT3E2RzRHVDd3LWV4bg?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T12:01:05+00:00", "published_display": "07 Jul 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inmune Bio (NASDAQ: INMB) director exercises 14,801 warrants at $1.40", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQWGJmaFdmWTBGWkN2Um9KMHNZR2FSc05Ba29jdkR5M0tVbldUT0pEc1RwWGRBZkNBWk1HdmsxU0UxS2NLTWtwVXZTaExpSXBWd2lsYjBUWXhtTmZaanc3Vld5VktJVy1sWE5UZjZodDVpbldaMUctR2RJZ0dUWGpmYmtIMW5Zd3psSFctQnhwbVAwOWpoTDdXYlAtYTdCYXRjVXUyOExYa3d5S1ky?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T11:02:18+00:00", "published_display": "07 Jul 2026 11:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (INMB) CSO exercises April 2024 warrants and extends remaining term", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSmF0S3dxVkhFTE1WcUQxMlptWFRFTkFLS3V1LXpOTHliamp1Z2xqZjZVTXhDWGtLbXdiVGt5VjFYMm0zZjA0UDhBM2FBcHBTZk1QRWJpNkgzVy1KLTVwbl9zdXo0ZW16d2xXQXJ1STFpWjg5NjdrajlHUm9KYjg4NUlYNXhxaVlieW85Q0lHMktUM2FFcTBwY1J4QUFOalV5Vmo3UXVKMjlWQUtV?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is INmune Bio (NASDAQ:INMB) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-01T11:07:53+00:00", "published_display": "01 Jul 2026 11:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Advances CORDStrom\u2122 Platform Patent Application in the U.S. Following Favorable International Written Opinion", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxONkZJVGx2S0YxUGtzQl9DQXo2SHhFLVZBWE1ZdDdIM3JvVV9IT2paaW1hZ0xKcXIwd3JqUU9aVHpuVXFuVnVYUE8tOEZqVWZuUjBkeWtfQUhCQlZnVFZhNGM1U044NTRNX2FIQlBreDcwUWpGQnItUkpKOXhlTmV0SkpXRmdfWTN0S2J4YWpWVVgwbGJ5MVZUMEZBZElEbkE3?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio moves CORDStrom into U.S. patent review", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQYmRNdENBZW1jZ2Rqb0Rtd3RXT2JHd1RRd2JHeHdJX2ZvczlxRHNUUTF5dFJaS2N1WGp0bjl6bC16a1QzOUp5X0JVckhVSEV1Y2RfOWxyeUMtQ1lfLVdIZ2wySUFmLUt6XzhTd2pxWkt6blNtdDc5NjlyRXFiMjg3Qi1saUd6WFRJOXg2Q0plVXgzNlpValY5b21LM3FOdmdPNzJtSFlibmtPTFFoazJpbmNGc3duQ0RIczJxRA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (NASDAQ: INMB) cuts warrant price, extends 2027 expiry", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWDRkaWhEaUJGbHRSbjBpblBOZ3JIcmttNWw1OTdOWmVTMTB3cE5YMGpSNmxLNFlmcnk5a0h4NzlLbmREMDRVaGprYmI5bEYzcjhTRHp4b2JfeXlSTjZ2WkViZGI0VEFWVlZmWnVqOGRYelRaTExZOWxOcTNZNHNfeHZUYjJ0d3daWmVoYjJ4OVAybFlpY2x1QkNYT01aV1FYQi1pV1V3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Gets UK Approval for Pediatric Plan for RDEB Treatment Candidate", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-gets-uk-approval-114035912.html", "source_name": "MT Newswires", "published_at": "2026-06-25T11:40:35+00:00", "published_display": "25 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom\u2122", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-inc-achieves-mhra-110000191.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T11:00:00+00:00", "published_display": "25 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio clears key UK pediatric review for Ebstrocel in RDEB", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNX3dacUI2NWRJeGROZXRXZS11RXVwR0ZxOXR5Xzc0Yk03RGtoenZnR3NkUFU4eG90OFRqZEtoVE96ZVU0empaaG00QnFEYWNWb25wQlEyZzhJaXpWT25GWEZjQWMtc0JOTXpIY0xpTTdKX0Rzc1YtSXA5TEpaZTJqWS1yYWFKRzc5RW8zRFZTUTNFS0lkV3lwbDJVbVVPUnhSbUZyMXplNHBxemVMNEVpaWliWUFkdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio's CORDStrom Gets Written Alignment on UK Conditional Marketing Authorization Application", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-apos-cordstrom-gets-125350191.html", "source_name": "MT Newswires", "published_at": "2026-06-23T12:53:50+00:00", "published_display": "23 Jun 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom\u2122 in RDEB", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-receives-mhra-written-120000119.html", "source_name": "GlobeNewswire", "published_at": "2026-06-23T12:00:00+00:00", "published_display": "23 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio wins MHRA backing for 2026 UK rare-disease filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZW9senJGMUpReEZOS1o3aThpdzBUZWktaUNOX3NFWmRBSU5xVXZIRm1JNmRXb2Vqb04xc0VRQjhrMmxMdm1KRVpieE9mTU43cjJwN1otYUFhYjNoYnU0dlJYdkFxR2dmeDZ5TmFuc0ZBWTMyV0dpMmhnZEZtR1RyU1paSXFaVzVGa3dIekFLVG9SVGxieEg2T3BIOXhqMmc2UkR6QlVwNFItVktyaHZtOUdvblI3bkJoM2VtNFVZRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (INMB) holders OK larger stock plan and evergreen share increases", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOYjNFelI0cU9IWEI2Z0E3eE00ckx4ZElvVTdVa1k4WDZNUHdqc3JDVTM1dFBDR3Bud294UG9vQTQxMHZ2a2RSbW93ZmhqYWNqZXlwUEU4QndzcjRnZUFOY2FMS2RZUi1uQjFwbnI4aDFjNHhraWJobFN3cmZKNHdpUUtacUdXZ042YnYxOENiaGt0SC04b3pibm1mSVpGVkVad09zUGVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Reports 'Statistically Significant Treatment Effect' in Phase 2 Alzheimer's Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmune-bio-reports-apos-statistically-135739954.html", "source_name": "MT Newswires", "published_at": "2026-06-02T13:57:39+00:00", "published_display": "02 Jun 2026 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10+ things to know in #MiamiTech: Bluelabs raises $7M, plus news from Betr, INmune Bio, I Squared Capital, OpenEvidence, Simpro Group, Endeavor Miami, Spearmint Energy, Titan America\u2019s innovation hub & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAJBVV95cUxQbHhXd2luQjE3aGx2SF9ja012NmF0N255QlVrMU8zOTgyLTRzNXBwdl9kSGRwdWVqeWs4ZnZFeFQzVjFzaGVhXzRhcGN5RnRqcGs2SEhPeHJKbU9jdl9oLV9kTGdNa2Yzel80QV9CTE9TemNjWVl3amdrR2EyWGs2LXhKMGpCM1pDbC1HLTFub2tjT3pPWHRaNkY4dEhNaHVDTTZ4Q1dqbHBiejhpOXlCNW8wdVdsRjFadDhhOTVYQWxlRm9YZ2gzc3lLRkJsWmZ2UFRBV1BTT2ltSkVLMGxxajJYdHliYjgzVm5lU1ZPR0R3VC1EWWxKQzNpZkNmQ3h5RVZIcnZQMlU3UlkyZkFpSWN3MTQyUkc3aEpwZUlSQV9wRmxOaGhMWTVqbGF4QWFTajFYTA?oc=5", "source_name": "Refresh Miami", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "INMUNE BIO ($INMB) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOb3IwNGlaNHgyRlU1aXZPRDRZNlJ6V2VqTkl4TU1pbmo0aTJtTmhFUUpnWGN6dmVIT1N1Y2M3ZUMzZWF2SjhROVdhLXRUaUNVVk1MUVNTb0lPMmRoc0pSUGpaOXdObTNxVUhramd1ZnVDX0VrbWQ3cFlYaG5jNjlZZUtHa2tYVnVnUnkw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeGVtSVREV0RtU2NPd0RLdkJ6XzdoSERMdXJveVVOTWhrNU5pd0RKWEMzVjBvSlk3WFZudl9ERERlVnRIaVIxLWFUMVFXdEdrdHlTWnlxdU9YYVFPb28yMVpLTkV1T2RUc1JlVXRXN1ZVNk9PUVFIMkIyUS1NT1Iyc0RvNzN6UFcyQjFYT2hIYnU3c01RcThWYg?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQUk9nZmNPVkhSUVZ3WGFIV19NbHEzeGE5Z1E4RDRYOEx2M01GTU41aldnUXh0ZkVrX0FGQlNRTnFYajhVbVhEVnZKUldOeXNHQVByMUN5cU9xOWM4UXpOSUNPaHRaN0pJSkxSRWdVbV8wMl9kSUpzeURWR1UtWW1tTktOM0x3MXFwbjR1bXd5N0s3T0t3eTZqcEMyand1aUJweFpiSWRKRW5Rc2gwNW1FWDEzYWJ1RlBwRlBoUS1qRGstLWFQVlZIa1pGMTFaeDMzN0E?oc=5", "source_name": "Reuters", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-says-study-shows-115035587.html", "source_name": "MT Newswires", "published_at": "2026-07-15T11:50:35+00:00", "published_display": "15 Jul 2026 11:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio\u2019s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-xpro1595-prevents-brain-110000293.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T11:00:00+00:00", "published_display": "15 Jul 2026 11:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio And 2 Other Promising Penny Stocks To Consider", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T17:11:43+00:00", "published_display": "13 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Inc (INMB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5UcElqMTJFWTktaW5zQzk4RkVjNldCS3ZQbzVsZlBfNTlJdlI1anItZnlfOG04RjNRV2N3dXBwNmVtd2s0LVJZa0NfTVFnbnVldjlsVzBDU1ppQzVDd0dQOWpZZmtPMTJUZXZ2UkFxaw?oc=5", "source_name": "TradingKey", "published_at": "2026-07-12T07:00:00+00:00", "published_display": "12 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer\u2019s Disease at AAIC", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-present-positive-phase-110000414.html", "source_name": "GlobeNewswire", "published_at": "2026-07-09T11:00:00+00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio says XPro imaging data at AAIC show early Alzheimer\u2019s brain changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQeE9ET2RKbUdaZFZSQkxsOWNOR3RDVUFzX1M4eDVzQ3JObUE5dFh1YzdKNmF0QWxvLXotN2RQa1JtLXhSTUlleVFDNF9uUWxZZVJTV3htNWtiNVJmY0NIQnMyY19hVGJDRnl1VVV6VGUxNi1uVmtfOXNETDlFa1lZZ1ZZY2JFR1JGQW9sZHY2ZnpOSlVPWkRVLUVhNHZKUzNLcXJnWEdjcks1YzViRERndFpwTklMdEswa0ZzRw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T11:00:00+00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 INmune Bio Inc For: 7 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNTE02MDJlazkzVUNFLUpiMFR3N3BsWHFFZzBCdW9XcHRWQm40TG9XbWtaaVpPMDZiazFjVEdvZFRxSGFzQkxwNWxsbkFZLXYwWnZRY21DZmZQT0NQd3hOMmRKZjlfckhDZHNJMlloS0tIWmFvVXh2d2xMS18yOVJyc3ExSTNVMFZaRWhMT3E2RzRHVDd3LWV4bg?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T12:01:05+00:00", "published_display": "07 Jul 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inmune Bio (NASDAQ: INMB) director exercises 14,801 warrants at $1.40", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQWGJmaFdmWTBGWkN2Um9KMHNZR2FSc05Ba29jdkR5M0tVbldUT0pEc1RwWGRBZkNBWk1HdmsxU0UxS2NLTWtwVXZTaExpSXBWd2lsYjBUWXhtTmZaanc3Vld5VktJVy1sWE5UZjZodDVpbldaMUctR2RJZ0dUWGpmYmtIMW5Zd3psSFctQnhwbVAwOWpoTDdXYlAtYTdCYXRjVXUyOExYa3d5S1ky?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T11:02:18+00:00", "published_display": "07 Jul 2026 11:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (INMB) CSO exercises April 2024 warrants and extends remaining term", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSmF0S3dxVkhFTE1WcUQxMlptWFRFTkFLS3V1LXpOTHliamp1Z2xqZjZVTXhDWGtLbXdiVGt5VjFYMm0zZjA0UDhBM2FBcHBTZk1QRWJpNkgzVy1KLTVwbl9zdXo0ZW16d2xXQXJ1STFpWjg5NjdrajlHUm9KYjg4NUlYNXhxaVlieW85Q0lHMktUM2FFcTBwY1J4QUFOalV5Vmo3UXVKMjlWQUtV?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is INmune Bio (NASDAQ:INMB) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-01T11:07:53+00:00", "published_display": "01 Jul 2026 11:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Advances CORDStrom\u2122 Platform Patent Application in the U.S. Following Favorable International Written Opinion", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxONkZJVGx2S0YxUGtzQl9DQXo2SHhFLVZBWE1ZdDdIM3JvVV9IT2paaW1hZ0xKcXIwd3JqUU9aVHpuVXFuVnVYUE8tOEZqVWZuUjBkeWtfQUhCQlZnVFZhNGM1U044NTRNX2FIQlBreDcwUWpGQnItUkpKOXhlTmV0SkpXRmdfWTN0S2J4YWpWVVgwbGJ5MVZUMEZBZElEbkE3?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio moves CORDStrom into U.S. patent review", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQYmRNdENBZW1jZ2Rqb0Rtd3RXT2JHd1RRd2JHeHdJX2ZvczlxRHNUUTF5dFJaS2N1WGp0bjl6bC16a1QzOUp5X0JVckhVSEV1Y2RfOWxyeUMtQ1lfLVdIZ2wySUFmLUt6XzhTd2pxWkt6blNtdDc5NjlyRXFiMjg3Qi1saUd6WFRJOXg2Q0plVXgzNlpValY5b21LM3FOdmdPNzJtSFlibmtPTFFoazJpbmNGc3duQ0RIczJxRA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (NASDAQ: INMB) cuts warrant price, extends 2027 expiry", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWDRkaWhEaUJGbHRSbjBpblBOZ3JIcmttNWw1OTdOWmVTMTB3cE5YMGpSNmxLNFlmcnk5a0h4NzlLbmREMDRVaGprYmI5bEYzcjhTRHp4b2JfeXlSTjZ2WkViZGI0VEFWVlZmWnVqOGRYelRaTExZOWxOcTNZNHNfeHZUYjJ0d3daWmVoYjJ4OVAybFlpY2x1QkNYT01aV1FYQi1pV1V3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Gets UK Approval for Pediatric Plan for RDEB Treatment Candidate", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-gets-uk-approval-114035912.html", "source_name": "MT Newswires", "published_at": "2026-06-25T11:40:35+00:00", "published_display": "25 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom\u2122", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-inc-achieves-mhra-110000191.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T11:00:00+00:00", "published_display": "25 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio clears key UK pediatric review for Ebstrocel in RDEB", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNX3dacUI2NWRJeGROZXRXZS11RXVwR0ZxOXR5Xzc0Yk03RGtoenZnR3NkUFU4eG90OFRqZEtoVE96ZVU0empaaG00QnFEYWNWb25wQlEyZzhJaXpWT25GWEZjQWMtc0JOTXpIY0xpTTdKX0Rzc1YtSXA5TEpaZTJqWS1yYWFKRzc5RW8zRFZTUTNFS0lkV3lwbDJVbVVPUnhSbUZyMXplNHBxemVMNEVpaWliWUFkdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio's CORDStrom Gets Written Alignment on UK Conditional Marketing Authorization Application", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-apos-cordstrom-gets-125350191.html", "source_name": "MT Newswires", "published_at": "2026-06-23T12:53:50+00:00", "published_display": "23 Jun 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom\u2122 in RDEB", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inmune-bio-receives-mhra-written-120000119.html", "source_name": "GlobeNewswire", "published_at": "2026-06-23T12:00:00+00:00", "published_display": "23 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio wins MHRA backing for 2026 UK rare-disease filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZW9senJGMUpReEZOS1o3aThpdzBUZWktaUNOX3NFWmRBSU5xVXZIRm1JNmRXb2Vqb04xc0VRQjhrMmxMdm1KRVpieE9mTU43cjJwN1otYUFhYjNoYnU0dlJYdkFxR2dmeDZ5TmFuc0ZBWTMyV0dpMmhnZEZtR1RyU1paSXFaVzVGa3dIekFLVG9SVGxieEg2T3BIOXhqMmc2UkR6QlVwNFItVktyaHZtOUdvblI3bkJoM2VtNFVZRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (INMB) holders OK larger stock plan and evergreen share increases", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOYjNFelI0cU9IWEI2Z0E3eE00ckx4ZElvVTdVa1k4WDZNUHdqc3JDVTM1dFBDR3Bud294UG9vQTQxMHZ2a2RSbW93ZmhqYWNqZXlwUEU4QndzcjRnZUFOY2FMS2RZUi1uQjFwbnI4aDFjNHhraWJobFN3cmZKNHdpUUtacUdXZ042YnYxOENiaGt0SC04b3pibm1mSVpGVkVad09zUGVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio Reports 'Statistically Significant Treatment Effect' in Phase 2 Alzheimer's Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inmune-bio-reports-apos-statistically-135739954.html", "source_name": "MT Newswires", "published_at": "2026-06-02T13:57:39+00:00", "published_display": "02 Jun 2026 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10+ things to know in #MiamiTech: Bluelabs raises $7M, plus news from Betr, INmune Bio, I Squared Capital, OpenEvidence, Simpro Group, Endeavor Miami, Spearmint Energy, Titan America\u2019s innovation hub & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAJBVV95cUxQbHhXd2luQjE3aGx2SF9ja012NmF0N255QlVrMU8zOTgyLTRzNXBwdl9kSGRwdWVqeWs4ZnZFeFQzVjFzaGVhXzRhcGN5RnRqcGs2SEhPeHJKbU9jdl9oLV9kTGdNa2Yzel80QV9CTE9TemNjWVl3amdrR2EyWGs2LXhKMGpCM1pDbC1HLTFub2tjT3pPWHRaNkY4dEhNaHVDTTZ4Q1dqbHBiejhpOXlCNW8wdVdsRjFadDhhOTVYQWxlRm9YZ2gzc3lLRkJsWmZ2UFRBV1BTT2ltSkVLMGxxajJYdHliYjgzVm5lU1ZPR0R3VC1EWWxKQzNpZkNmQ3h5RVZIcnZQMlU3UlkyZkFpSWN3MTQyUkc3aEpwZUlSQV9wRmxOaGhMWTVqbGF4QWFTajFYTA?oc=5", "source_name": "Refresh Miami", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INMUNE BIO ($INMB) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOb3IwNGlaNHgyRlU1aXZPRDRZNlJ6V2VqTkl4TU1pbmo0aTJtTmhFUUpnWGN6dmVIT1N1Y2M3ZUMzZWF2SjhROVdhLXRUaUNVVk1MUVNTb0lPMmRoc0pSUGpaOXdObTNxVUhramd1ZnVDX0VrbWQ3cFlYaG5jNjlZZUtHa2tYVnVnUnkw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeGVtSVREV0RtU2NPd0RLdkJ6XzdoSERMdXJveVVOTWhrNU5pd0RKWEMzVjBvSlk3WFZudl9ERERlVnRIaVIxLWFUMVFXdEdrdHlTWnlxdU9YYVFPb28yMVpLTkV1T2RUc1JlVXRXN1ZVNk9PUVFIMkIyUS1NT1Iyc0RvNzN6UFcyQjFYT2hIYnU3c01RcThWYg?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQUk9nZmNPVkhSUVZ3WGFIV19NbHEzeGE5Z1E4RDRYOEx2M01GTU41aldnUXh0ZkVrX0FGQlNRTnFYajhVbVhEVnZKUldOeXNHQVByMUN5cU9xOWM4UXpOSUNPaHRaN0pJSkxSRWdVbV8wMl9kSUpzeURWR1UtWW1tTktOM0x3MXFwbjR1bXd5N0s3T0t3eTZqcEMyand1aUJweFpiSWRKRW5Rc2gwNW1FWDEzYWJ1RlBwRlBoUS1qRGstLWFQVlZIa1pGMTFaeDMzN0E?oc=5", "source_name": "Reuters", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 74, "total_relevant": 33, "sentiment_summary": {"positive": 6, "negative": 3, "neutral": 24, "score": 51, "total": 33, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 11.35, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 1.94, "latest_week": "2026-07-10", "one_week_move": 14.1, "four_week_move": 56.5, "twelve_week_move": 33.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.484867, "market_dynamics_buy_signal": false, "relative_strength": -3.335452, "fair_value_gap": -67.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.798, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+14.1% over one week, +56.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 8}, {"label": "Market source", "count": 7}, {"label": "MT Newswires", "count": 4}, {"label": "GlobeNewswire", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "TradingKey", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Refresh Miami", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 10}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+14.1% over one week, +56.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury"}], "updated_at": "2026-07-16T09:44:07.877951+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}